These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 36050304)

  • 1. SARS-CoV-2 vaccination induces mucosal antibody responses in previously infected individuals.
    Sano K; Bhavsar D; Singh G; Floda D; Srivastava K; Gleason C; ; Carreño JM; Simon V; Krammer F
    Nat Commun; 2022 Sep; 13(1):5135. PubMed ID: 36050304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salivary and serum IgA and IgG responses to SARS-CoV-2-spike protein following SARS-CoV-2 infection and after immunization with COVID-19 vaccines.
    Li D; Calderone R; Nsouli TM; Reznikov E; Bellanti JA
    Allergy Asthma Proc; 2022 Sep; 43(5):419-430. PubMed ID: 36065108
    [No Abstract]   [Full Text] [Related]  

  • 3. Mucosal antibody responses to SARS-CoV-2 booster vaccination and breakthrough infection.
    Bhavsar D; Singh G; Sano K; Gleason C; Srivastava K; ; Carreno JM; Simon V; Krammer F
    mBio; 2023 Dec; 14(6):e0228023. PubMed ID: 38092666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peritoneal Administration of a Subunit Vaccine Encapsulated in a Nanodelivery System Not Only Augments Systemic Responses against SARS-CoV-2 but Also Stimulates Responses in the Respiratory Tract.
    Jearanaiwitayakul T; Apichirapokey S; Chawengkirttikul R; Limthongkul J; Seesen M; Jakaew P; Trisiriwanich S; Sapsutthipas S; Sunintaboon P; Ubol S
    Viruses; 2021 Nov; 13(11):. PubMed ID: 34835008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection.
    Garrett ME; Galloway JG; Wolf C; Logue JK; Franko N; Chu HY; Matsen FA; Overbaugh JM
    Elife; 2022 Jan; 11():. PubMed ID: 35072628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secretory IgA and T cells targeting SARS-CoV-2 spike protein are transferred to the breastmilk upon mRNA vaccination.
    Gonçalves J; Juliano AM; Charepe N; Alenquer M; Athayde D; Ferreira F; Archer M; Amorim MJ; Serrano F; Soares H
    Cell Rep Med; 2021 Dec; 2(12):100468. PubMed ID: 34873588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-Resolution Linear Epitope Mapping of the Receptor Binding Domain of SARS-CoV-2 Spike Protein in COVID-19 mRNA Vaccine Recipients.
    Nitahara Y; Nakagama Y; Kaku N; Candray K; Michimuko Y; Tshibangu-Kabamba E; Kaneko A; Yamamoto H; Mizobata Y; Kakeya H; Yasugi M; Kido Y
    Microbiol Spectr; 2021 Dec; 9(3):e0096521. PubMed ID: 34756082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Mucosal and Serological Immune Responses to the Novel Coronavirus (SARS-CoV-2) Vaccines.
    Chan RWY; Liu S; Cheung JY; Tsun JGS; Chan KC; Chan KYY; Fung GPG; Li AM; Lam HS
    Front Immunol; 2021; 12():744887. PubMed ID: 34712232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An ELISA-Based Method to Measure Mucosal Antibody Responses Against SARS-CoV-2 in Human Saliva.
    Bhavsar D; Sano K; Singh G; Krammer F
    Curr Protoc; 2024 Apr; 4(4):e1024. PubMed ID: 38578049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting.
    Li Z; Xiang T; Liang B; Deng H; Wang H; Feng X; Quan X; Wang X; Li S; Lu S; Yang X; Wang B; Zelinskyy G; Trilling M; Sutter K; Lu M; Dittmer U; Yang D; Zheng X; Liu J
    Front Immunol; 2021; 12():802858. PubMed ID: 35003131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal inoculation of an MVA-based vaccine induces IgA and protects the respiratory tract of hACE2 mice from SARS-CoV-2 infection.
    Americo JL; Cotter CA; Earl PL; Liu R; Moss B
    Proc Natl Acad Sci U S A; 2022 Jun; 119(24):e2202069119. PubMed ID: 35679343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of elastase enhances the adjuvanticity of alum and promotes anti-SARS-CoV-2 systemic and mucosal immunity.
    Kim E; Attia Z; Woodfint RM; Zeng C; Kim SH; Steiner HE; Shukla RK; Liyanage NPM; Ghimire S; Li J; Renukaradhya GJ; Satoskar AR; Amer AO; Liu SL; Cormet-Boyaka E; Boyaka PN
    Proc Natl Acad Sci U S A; 2021 Aug; 118(34):. PubMed ID: 34353890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response and Duration of Serum Anti-SARS-CoV-2 Antibodies After Inactivated Vaccination Within 160 Days.
    Xu QY; Xue JH; Xiao Y; Jia ZJ; Wu MJ; Liu YY; Li WL; Liang XM; Yang TC
    Front Immunol; 2021; 12():786554. PubMed ID: 35003104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unmasking the potential of secretory IgA and its pivotal role in protection from respiratory viruses.
    Sinha D; Yaugel-Novoa M; Waeckel L; Paul S; Longet S
    Antiviral Res; 2024 Mar; 223():105823. PubMed ID: 38331200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of SARS-CoV-2-Specific Secretory IgA and Neutralizing Antibodies in the Nasal Secretions of Exposed Seronegative Individuals.
    Chwa JS; Kim M; Lee Y; Cheng WA; Shin Y; Jumarang J; Bender JM; Pannaraj PS
    Viruses; 2024 May; 16(6):. PubMed ID: 38932145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Boosting of cross-reactive antibodies to endemic coronaviruses by SARS-CoV-2 infection but not vaccination with stabilized spike.
    Crowley AR; Natarajan H; Hederman AP; Bobak CA; Weiner JA; Wieland-Alter W; Lee J; Bloch EM; Tobian AAR; Redd AD; Blankson JN; Wolf D; Goetghebuer T; Marchant A; Connor RI; Wright PF; Ackerman ME
    Elife; 2022 Mar; 11():. PubMed ID: 35289271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid increase in salivary IgA and broad recognition of spike protein following SARS-CoV-2 vaccination.
    Ota K; Sakai H; Sasaki D; Mitsumoto-Kaseida F; Sakamoto K; Kosai K; Hasegawa H; Takazono T; Izumikawa K; Mukae H; Tun MMN; Morita K; Yanagihara K
    Virus Res; 2024 Jan; 339():199294. PubMed ID: 38056502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucosal immunity to severe acute respiratory syndrome coronavirus 2 infection.
    Fröberg J; Diavatopoulos DA
    Curr Opin Infect Dis; 2021 Jun; 34(3):181-186. PubMed ID: 33899752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Levels of Nasal, Salivary, and Plasma Antibody to Severe Acute Respiratory Syndrome Coronavirus 2 During Natural Infection and After Vaccination.
    Cohen JI; Dropulic L; Wang K; Gangler K; Morgan K; Liepshutz K; Krogmann T; Ali MA; Qin J; Wang J; Vogel JS; Lei Y; Suzuki-Williams LP; Spalding C; Palmore TN; Burbelo PD
    Clin Infect Dis; 2023 Apr; 76(8):1391-1399. PubMed ID: 36482505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Gestational Age at Coronavirus Disease 2019 (COVID-19) Vaccination, History of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection, and a Vaccine Booster Dose With Maternal and Umbilical Cord Antibody Levels at Delivery.
    Yang YJ; Murphy EA; Singh S; Sukhu AC; Wolfe I; Adurty S; Eng D; Yee J; Mohammed I; Zhao Z; Riley LE; Prabhu M
    Obstet Gynecol; 2022 Mar; 139(3):373-380. PubMed ID: 34963127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.